BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $1.61 and last traded at $1.50, with a volume of 46497 shares traded. The stock had previously closed at $1.53.
BioRestorative Therapies Stock Down 2.0 %
The firm’s 50-day simple moving average is $1.61 and its 200-day simple moving average is $1.60. The firm has a market capitalization of $2.46 billion, a PE ratio of -0.03 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- How to invest in marijuana stocks in 7 steps
- How to Master Trading Discipline: Overcome Emotional Challenges
- What Are Dividend Champions? How to Invest in the Champions
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- The How and Why of Investing in Gold Stocks
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
